Involvement of neuropeptide Y in the acute, chronic and withdrawal responses of morphine in nociception in neuropathic rats: Behavioral and neuroanatomical correlates

Neuropeptides

Volumn 43, Issue 4, 2009, Pages 303-314

  Upadhya, Manoj A ^a   Dandekar, Manoj P ^a   Kokare, Dadasaheb M ^a   Singru, Praful S ^b   Subhedar, Nishikant K ^c  

^a RTM NAGPUR UNIVERSITY   (India)

^b TUFTS MEDICAL CENTER   (United States)

^c INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH   (India)

Author keywords

Antinociception; Immunocytochemistry; Morphine; Neuropathic pain; Neuropeptide Y; Thermal paw withdrawal test

Indexed keywords

MORPHINE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y [31 LEUCINE 34 PROLINE]; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG DOSE COMPARISON; DRUG TOLERANCE; DRUG WITHDRAWAL; HYPERALGESIA; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; LOCUS CERULEUS; MALE; NERVE FIBER; NERVE LIGATION; NEUROANATOMY; NEUROPATHY; NOCICEPTION; NONHUMAN; OSMOTIC MINIPUMP; PAIN THRESHOLD; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PROTEIN INTERACTION; RAT; SCIATIC NERVE; WITHDRAWAL REFLEX;

ANALGESICS, OPIOID; ANIMALS; ARGININE; BEHAVIOR, ANIMAL; DRUG TOLERANCE; HYPERALGESIA; MALE; MORPHINE; NEUROPEPTIDE Y; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE Y; SCIATIC NERVE; SUBSTANCE WITHDRAWAL SYNDROME;

RATTUS;

EID: 67651087154     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2009.05.003     Document Type: Article

References (61)

1. Arner S., and Meyerson B.A. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 33 (1988) 11-23
2. Basbaum A.I., and Fields H.L. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Ann. Rev. Neurosci. 7 (1984) 309-338
3. Bennett G.J., and Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1988) 87-107
4. Besse D., Lombard M.C., Perrot S., and Besson J.M. Regulation of opioid binding sites in the superficial dorsal horn at the rat spinal cord following loose ligation of the sciatic nerve: comparison with sciatic nerve section and lumbar dorsal rhizotomy. Neuroscience 50 (1992) 921-933
5. Bison S., and Crews F. Alcohol withdrawal increases neuropeptide Y immunoreactivity in rat brain. Alcohol Clin. Exp. Res. 27 (2003) 1173-1183
6. Christensen D., and Kayser V. The development of pain-related behavior and opioid tolerance after neuropathy-inducing surgery and sham surgery. Pain 88 (2000) 231-238
7. Chronwall B.M., DiMaggio D.A., Massari V.J., Pickel V.M., Ruggiero D.A., and O'Donohue T.L. The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience 15 (1985) 1159-1181
8. Clausen T.R., Moller M., and Woldbye D.P. Inhibitory effect of neuropeptide Y on morphine withdrawal is accompanied by reduced c-fos expression in specific brain regions. J. Neurosci. Res. 64 (2001) 410-417
9. Dandekar M.P., Singru P.S., Kokare D.M., Lechan R.M., Thim L., Clausen J.T., and Subhedar N.K. Importance of cocaine- and amphetamine-regulated transcript peptide in the central nucleus of amygdala in anxiogenic responses induced by ethanol withdrawal. Neuropsychopharmacology 33 (2008) 1127-1136
10. Dandekar M.P., Singru P.S., Kokare D.M., and Subhedar N.K. Transient up-regulation of cocaine- and amphetamine-regulated transcript peptide (CART) immunoreactivity following ethanol withdrawal in rat hypothalamus. Brain Res. 1240 (2008) 119-131
11. de Quidt M.E., and Emson P.C. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system-I. Radioimmunoassay and chromatographic characterization. Neuroscience 18 (1986) 527-543
12. deGroot J.F., Coggeshall R.E., and Carlton S.M. The reorganization of μ-opioid receptors in the rat dorsal horn following peripheral axotomy. Neurosci. Lett. 233 (1997) 113-116
13. Dirig D.M., Salami A., Rathbun M.L., Ozaki G.T., and Yaksh T.L. Characterization of variables defining hindpaw withdrawal latency evoked by radiant thermal stimuli. J. Neurosci. Methods 76 (1997) 183-191
14. Granados-Soto V., Sanchez-Ramirez G., la Torre M.R., Caram-Salas N.L., Medina-Santillan R., and Reyes-Garcia G. Effect of diclofenac on the antiallodynic activity of vitamin B12 in a neuropathic pain model in the rat. Proc. West. Pharmacol. Soc. 47 (2004) 92-94
15. Gustafson H.B., Gerald C., Durkin M.M., Smith K.E., Walker M.W., Moralishvilli A., Vaysse P.J.-J., Weinshank R.W., and Branchek T.A. Localization of the mRNA encoding a novel NPY receptor subtype in rat brain. Soc. Neurosci. Abstr. 22 (1996) 1682
16. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
17. Hayward M.D., Duman R.S., and Nestler E.J. Induction of the c-fos proto-oncogene during opiate withdrawal in the locus coeruleus and other regions of rat brain. Brain Res. 525 (1990) 256-266
18. Holmes P.V., Bartolomeis A., Koprivica V., and Crawley J.N. Lack of effect of chronic morphine treatment and naloxone-precipitated withdrawal on tyrosine hydroxylase, galanin and neuropeptide Y mRNA levels in the rat locus coeruleus. Synapse 19 (1995) 197-205
19. Hua X.Y., Boublik J.H., Spicer M.A., Rivier J.E., Brown M.R., and Yaksh T.L. The antinociceptive effects of spinally administered neuropeptide Y in the rat: systematic studies on structure-activity relationship. J. Pharmacol. Exp. Ther. 258 (1991) 243-248
20. Ji Y., Murphy A.Z., and Traub R.J. Sex differences in morphine-induced analgesia of visceral pain are supraspinally and peripherally mediated. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291 (2006) R307-R314
21. Kalange A.S., Kokare D.M., Singru P.S., Upadhya M.A., Chopde C.T., and Subhedar N.K. Central administration of selective melanocortin-4 receptor antagonist HS014 prevents morphine tolerance and withdrawal hyperalgesia. Brain Res. 1181 (2007) 10-20
22. Kim S.Y., Chudapongse N., Lee S.M., Levin M.C., Oh J.T., Park H.J., and Ho I.K. Proteomic analysis of phosphotyrosyl proteins in morphine-dependent rat brains. Mol. Brain Res. 133 (2005) 58-70
23. Kokare D.M., Chopde C.T., and Subhedar N.K. Participation of alpha-melanocyte stimulating hormone in ethanol-induced anxiolysis and withdrawal anxiety in rats. Neuropharmacology 51 (2006) 536-545
24. Kokare D.M., Singru P.S., Dandekar M.P., Chopde C.T., and Subhedar N.K. Involvement of alpha-melanocyte stimulating hormone (α-MSH) in differential ethanol exposure and withdrawal related depression in rat: neuroanatomical-behavioral correlates. Brain Res. 1216 (2008) 53-67
25. Koob G.F., Maldonado R., and Stinus L. Neural substrates of opiate withdrawal. TINS 15 (1992) 186-191
26. Ma W., and Bisby M.A. Partial sciatic nerve ligation induced more dramatic increase of neuropeptide Y immunoreactive axonal fibers in the gracile nucleus of middle-aged rats than in young adult rats. J. Neurosci. Res. 60 (2000) 520-530
27. Maldonado R., Valverde O., Garbay C., and Roques B.P. Protein kinases in the locus coeruleus and periaqueductal gray matter are involved in the expression of opiate withdrawal. Naunyn-Schmiedeberg's Arch. Pharmacol. 352 (1995) 565-575
28. Mao J., Price D.D., and Mayer D.J. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain 61 (1995) 353-364
29. Matos F.F., Rollema H., Taiwo Y.O., Levine J.D., and Basbaum A.I. Relationship between analgesia and extracellular morphine in brain and spinal cord in awake rats. Brain Res. 693 (1995) 187-195
30. Milne B., Cervenko F.W., Jhamandas K., and Sutak M. Intrathecal clonidine: analgesia and effect on opiate withdrawal in the rat. Anesthesiology 62 (1985) 34-38
31. Nichols M.L., Lopez Y., Ossipov M.H., Bian D., and Porreca F. Enhancement of the antiallodynic and antinociceptive efficacy of spinal morphine by antisera to dynorphin A (1-13) or MK-801 in a nerve-ligation model of peripheral neuropathy. Pain 69 (1997) 317-322
32. Pages N., Orosco M., Fournier G., Rouch C., Hafi A., Gourch A., Comoy E., and Bohuon C. The effects of chronic administration of morphine on the levels of brain and adrenal catecholamines and neuropeptide Y in rats. Gen. Pharmacol. 22 (1991) 943-947
33. Pages N., Orosco M., Rouch C., Fournier G., Comoy E., and Bohuon C. Brain and adrenal monoamines and neuropeptide Y in codeine tolerant rats. Gen. Pharmacol. 23 (1992) 159-163
34. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1998), Academic Press, London
35. Petraschka M., Li S., Gilbert T.L., Westenbroek R.E., Bruchas M.R., Schreiber S., Lowe J., Low M.J., Pintar J.E., and Chavkin C. The absence of endogenous β-endorphin selectively blocks phosphorylation and desensitization of μ-opioid receptors following partial sciatic nerve ligation. Neuroscience 146 (2007) 1795-1807
36. Przewlocka B., Mika J., Labuz D., Toth G., and Przewocki R. Spinal analgesic action of endomorphins in acute, inflammatory and neuropathic pain in rats. Eur. J. Pharmacol. 367 (1999) 189-196
37. Raghavendra V., Rutkowski M.D., and DeLeo J.A. The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. J. Neurosci. 22 (2002) 9980-9989
38. Raghavendra V., Tanga F.Y., and DeLeo J.A. Attenuation of morphine tolerance, withdrawal-induced hyperalgesia and associated spinal inflammatory immune responses by propentofylline in rats. Neuropsychopharmacology 29 (2004) 327-334
39. Rao T.L., Kokare D.M., Sarkar S., Khisti R.T., Chopde C.T., and Subhedar N. GABAergic agents prevent alpha-melanocyte stimulating hormone induced anxiety and anorexia in rats. Pharmacol. Biochem. Behav. 76 (2003) 417-423
40. Roy A., and Pandey S.C. The decreased cellular expression of neuropeptide Y protein in rat brain structures during ethanol withdrawal after chronic ethanol exposure. Alcohol Clin. Exp. Res. 26 (2002) 796-803
41. Sakharkar A.J., Singru P.S., Sarkar K., and Subhedar N.K. Neuropeptide Y in the forebrain of the adult male cichlid fish Oreochromis mossambicus: distribution, effects of castration and testosterone replacement. J. Comp. Neurol. 489 (2005) 148-165
42. 1 receptors mediate morphine-induced reductions of natural killer cell activity. J. Neuroimmunol. 177 (2006) 18-26
43. Segal M., and Sandberg D. Analgesia produced by electrical stimulation of catecholamine nuclei in the rat brain. Brain Res. 123 (1977) 369-372
44. Silva A.P., Cavadas C., and Grouzmann E. Neuropeptide Y and its receptors as potential therapeutic drug targets. Clin. Chim. Acta 326 (2002) 3-25
45. Smith P.A., Moran T.D., Abdulla F., Tumber K.K., and Taylor B.K. Spinal mechanisms of NPY analgesia. Peptides 28 (2007) 464-474
46. Taiwo O.B., and Taylor B.K. Antihyperalgesic effects of intrathecal neuropeptide Y during inflammation are mediated by Y1 receptors. Pain 96 (2002) 353-363
47. Takeda K., Sawamura S., Tamai H., Sekiyama H., and Hanaoka K. Role for cyclooxygenase 2 in the development and maintenance of neuropathic pain and spinal glial activation. Anesthesiology 103 (2005) 837-844
48. Tallarida R.J., Stone D.J., McCary J.D., and Raffa R.B. Response surface analysis of synergism between morphine and clonidine. J. Pharmacol. Exp. Ther. 289 (1999) 8-13
49. Taylor B.K., Abhyankar S.S., Vo N.T., Kriedt C.L., Churi S.B., and Urban J.H. Neuropeptide Y acts at Y1 receptors in the rostral ventral medulla to inhibit neuropathic pain. Pain 131 (2007) 83-95
50. Tracey D.J., Romm M.A., and Yao N.N. Peripheral hyperalgesia in experimental neuropathy: exacerbation by neuropeptide Y. Brain Res. 669 (1995) 245-254
51. Wakisaka S., Kajander K.C., and Bennett G.J. Effects of peripheral nerve injuries and tissue inflammation on the levels of neuropeptide Y-like immunoreactivity in rat primary afferent neurons. Brain Res. 598 (1992) 349-352
52. Wang J.Z. Microinjection of neuropeptide Y into periaqueductal grey produces anti-nociception in rats with mononeuropathy. Acta Physiol. Sin. 56 (2004) 79-82
53. White D.M. Intrathecal neuropeptide Y exacerbates nerve injury-induced mechanical hyperalgesia. Brain Res. 750 (1997) 141-146
54. Woldbye D.P., Klemp K., and Madsen T.M. Neuropeptide Y attenuates naloxone-precipitated morphine withdrawal via Y5-like receptors. J. Pharmacol. Exp. Ther. 284 (1998) 633-636
55. Xu X.J., Hao J.X., Hokfelt T., and Wiesenfeld-Hallin Z. The effects of intrathecal neuropeptide-Y on the spinal nociceptive flexor reflex in rats with intact sciatic-nerves and after peripheral axotomy. Neuroscience 63 (1994) 817-826
56. 2+ channel enhanced morphine analgesia and reduced morphine tolerance. Eur. J. Neurosci. 20 (2004) 3516-3519
57. Yoo J.H., Cho J.H., Lee S.Y., Loh H.H., Ho I.K., and Jang C.G. A lack of μ-opioid receptors modulates the expressions of neuropeptide Y and substance P mRNA. Neurosci. Lett. 384 (2005) 29-32
58. Zhang L.P., and Wang L. Changes of brain neuropeptide Y and its receptors in rats with flurazepam tolerance and dependence. Acta Pharmacol. Sin. 26 (2005) 1290-1296
59. Zhang X., Bao L., Shi T.J., Ju G., Elde R., and Hokfelt T. Down-regulation of μ-opioid receptors in rat and monkey dorsal root ganglion neurons and spinal cord after peripheral axotomy. Neuroscience 82 (1998) 223-240
60. Zhang Y.X., Lundeberg T., and Yu L.C. Involvement of neuropeptide Y and Y1 receptor in antinociception in nucleus raphe magnus of rats. Regul. Pept. 95 (2000) 109-113
61. Zhu H., Ho I.K., Kramer R.E., Baker R.C., and Rockhold R.W. Methyl parathion masks withdrawal from physical dependence on morphine. Int. J. Mol. Sci. 3 (2002) 1073-1081